The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hence, it plays a critical role in establishing many major human ailments. including Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), malaria, and Ras related cancers.”
From Synthesis and NMR Characterization of the Prenylated Peptide, a-Factor (2019) · cites this paper as Eckert et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statins Reduce Amyloid-β Production through Inhibition of Protein Isoprenylation
Ostrowski, S. M., Wilkinson, B. L., Golde, T. E., & Landreth, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702640200 · Cited by 180
Presenilins interact with Rab11, a small GTPase involved in the regulation of vesicular transport
Dumanchin, C. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1263 · Cited by 99
Research works printed but not linked: 24
- Bruen, 2008, Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease, Brain, 131, 2455, 10.1093/brain/awn151 · DOI · Paper page
- Chetelat, 2008, Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease, Brain, 131, 60, 10.1093/brain/awm288 · DOI · Paper page
- Cole, 2006, Isoprenoids and Alzheimer's disease: a complex relationship, Neurobiol. Dis., 22, 209, 10.1016/j.nbd.2005.11.007 · DOI
- Cole, 2005, Statins cause intracellular accumulation of APP, beta-secretase cleaved fragments, and Abeta via an isoprenoid-dependent mechanism, J. Biol. Chem., 280, 18755, 10.1074/jbc.M413895200 · DOI
- Franke, 2007, Bcl-2 upregulation and neuroprotection in guinea pig brain following chronic simvastatin treatment, Neurobiol. Dis., 25, 438, 10.1016/j.nbd.2006.10.004 · DOI
- Hampton, 2002, Proteolysis and sterol regulation, Annu. Rev. Cell Dev. Biol., 18, 345, 10.1146/annurev.cellbio.18.032002.131219 · DOI
- Hooff, 2008, Isoprenoid quantitation in human brain tissue: a validated HPLC-fluorescence detection method for endogenous farnesyl- (FPP) and geranylgeranylpyrophosphate (GGPP), Anal. Bioanal. Chem., 392, 673, 10.1007/s00216-008-2306-3 · DOI
- Johnson-Anuna, 2005, Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex, J. Pharmacol. Exp. Ther., 312, 786, 10.1124/jpet.104.075028 · DOI · Paper page
- Kukar, 2005, Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production, Nat. Med., 11, 545, 10.1038/nm1235 · DOI · Paper page
- Lee, 2002, Implication of the small GTPase Rac1 in the generation of reactive oxygen species in response to beta-amyloid in C6 astroglioma cells, Biochem. J., 366, 937, 10.1042/bj20020453 · DOI
- Li, 2007, Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease, Neurology, 69, 878, 10.1212/01.wnl.0000277657.95487.1c · DOI · Paper page
- Lutz, 1992, Feedback inhibition of polyisoprenyl pyrophosphate synthesis from mevalonate in vitro. Implications for protein prenylation, J. Biol. Chem., 267, 7983, 10.1016/S0021-9258(18)42396-4 · doi:10.1016/s0021-9258(18)42396-4
- McTaggart, 2006, Isoprenylated proteins, Cell Mol. Life Sci., 63, 255, 10.1007/s00018-005-5298-6 · DOI · Paper page
- Murthy, 2005, Regulation of fatty acid synthesis by farnesyl pyrophosphate, J. Biol. Chem., 280, 41793, 10.1074/jbc.M504101200 · DOI
- Ridley, 2001, Rho proteins: linking signaling with membrane trafficking, Traffic, 2, 303, 10.1034/j.1600-0854.2001.002005303.x · DOI · Paper page
- Roskoski, 2003, Protein prenylation: a pivotal posttranslational process, Biochem. Biophys. Res. Commun., 303, 1, 10.1016/S0006-291X(03)00323-1 · DOI
- Scheper, 2004, Rab6 membrane association is dependent of Presenilin 1 and cellular phosphorylation events, Brain Res. Mol. Brain Res., 122, 17, 10.1016/j.molbrainres.2003.11.013 · DOI
- Scheper, 2007, Rab6 is increased in Alzheimer's disease brain and correlates with endoplasmic reticulum stress, Neuropathol. Appl. Neurobiol., 33, 523, 10.1111/j.1365-2990.2007.00846.x · DOI
- Sparks, 2008, Reduced risk of incident AD with elective statin use in a clinical trial cohort, Curr. Alzheimer Res., 5, 416, 10.2174/156720508785132316 · DOI · Paper page
- Takai, 2001, Small GTP-binding proteins, Physiol. Rev., 81, 153, 10.1152/physrev.2001.81.1.153 · DOI · Paper page
- Tong, 2008, Quantitative determination of farnesyl and geranylgeranyl diphosphate levels in mammalian tissue, Anal. Biochem., 378, 138, 10.1016/j.ab.2008.04.021 · DOI
- Tong, 2005, Simultaneous determination of farnesyl and geranylgeranyl pyrophosphate levels in cultured cells, Anal. Biochem., 336, 51, 10.1016/j.ab.2004.09.024 · doi:10.1016/j.ab.2004.09.024
- Urano, 2005, Association of active gamma-secretase complex with lipid rafts, J. Lipid. Res., 46, 904, 10.1194/jlr.M400333-JLR200 · DOI
- Zhou, 2007, Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis, Dement. Geriatr. Cogn. Disord., 23, 194, 10.1159/000099037 · DOI
Cited by
Linking lipids to Alzheimer's disease: cholesterol and beyond
Di Paolo, G., & Kim, T.-W. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3012 · Cited by 972
Sterol regulatory element binding protein 1 couples mechanical cues and lipid metabolism
Bertolio, R., Napoletano, F., Mano, M., Maurer-Stroh, S., Fantuz, M., Zannini, A., Bicciato, S., Sorrentino, G., & Del Sal, G. (2019) · Nature Communications · doi:10.1038/s41467-019-09152-7 · Cited by 297
Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis
Wood, W. G., Li, L., Müller, W. E., & Eckert, G. P. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12637 · Cited by 194
Self-citationVarma, V. R., Büşra Lüleci, H., Oommen, A. M., Varma, S., Blackshear, C. T., Griswold, M. E., An, Y., Roberts, J. A., O’Brien, R., Pletnikova, O., et al. (2021) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-021-00064-9 · Cited by 153
Barbero-Camps, E., Fernández, A., Martínez, L., Fernández-Checa, J. C., & Colell, A. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt201 · Cited by 114
Metadata
- Authors
- Eckert, G. P., Hooff, G. P., Strandjord, D. M., Igbavboa, U., Volmer, D. A., Müller, W. E., & Wood, W. G.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 35
- Issue
- 2
- Pages
- 251-257
- ISSN
- 0969-9961
- Cited by
- 108
- References
- 2
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/3.0/ (vor, 1445 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients. https://app.cochat.ai/papers/10.1016/j.nbd.2009.05.005
- The paper
- Eckert, G. P., Hooff, G. P., Strandjord, D. M., Igbavboa, U., Volmer, D. A., Müller, W. E., & Wood, W. G. (2009). Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2009.05.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.